School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
School of Pharmacy, The University of Queensland, Pharmacy Australia Centre of Excellence, Brisbane, QLD, Australia.
J Drug Target. 2021 Mar;29(3):310-322. doi: 10.1080/1061186X.2020.1835923. Epub 2020 Oct 27.
Numerous skin disorders and diseases are related to oxidative stress. The application of an antioxidant, serving as a strong defense agent against oxidation, is of great interest in dermatology yet remains challenging for delivery. This paper aimed to develop a niosome carrier system to deliver the antioxidant (+) Catechin into the skin. (+) Catechin-loaded niosomes were prepared using film hydration technique and the physicochemical properties of drug-loaded niosomes were characterised and investigated by a series of and studies. The optimised formulation displayed an acceptable size in nanoscale (204 nm), high drug entrapment efficiency (49%) and amorphous state of drug in niosomes. It was found that (+) Catechin-loaded niosomes could effectively prolong the drug release. Drug deposition in the viable layers of human skin was significantly enhanced when niosomal carriers were applied ( < 0.05). Compared to the pure drug, the niosomal formulation had a greater protective effect on the human skin fibroblasts (Fbs). This is consistent with the observation of internalisation of niosomes by Fbs which was concentration-, time- and temperature-dependent, an energy-dependent process of endocytosis. The research highlighted that niosomes are potential topical carriers for dermal delivery of antioxidants in skin-care and pharmaceutical products.
许多皮肤疾病与氧化应激有关。抗氧化剂作为一种强大的抗氧化防御剂,在皮肤病学中具有重要的应用价值,但在递送上仍然具有挑战性。本文旨在开发一种脂质体载体系统,将抗氧化剂(+)儿茶素递送到皮肤中。采用薄膜水化技术制备(+)儿茶素脂质体,通过一系列 和 研究对载药脂质体的理化性质进行了表征和研究。优化的配方显示出纳米级(204nm)的可接受粒径、高药物包封效率(49%)和药物在脂质体中的无定形状态。结果发现,(+)儿茶素脂质体能够有效地延长药物释放。当应用脂质体载体时,药物在人皮肤活层中的沉积显著增加( < 0.05)。与纯药物相比,脂质体制剂对人皮肤成纤维细胞(Fbs)具有更大的保护作用。这与 Fbs 内化脂质体的观察结果一致,内化过程是浓度、时间和温度依赖性的,是一种能量依赖性的内吞作用过程。该研究强调了脂质体作为皮肤抗氧化剂经皮给药的潜在局部载体,可用于皮肤护理和制药产品。